Clinical Trial Update: Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating far infrared irradiation for Huntington's disease, with no results reported and the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: GAAD Medical Research Institute Inc. | Conditions: Huntington Disease | Phase 1 | Status: UNKNOWN